Weill Cornell Medicine has received a three-year, $2.5 million grant from the Department of Defense to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.
The Center for Technology Licensing brought together Cornell inventors in Ithaca and at Weill Cornell Medicine for Bearers of Innovation: A One Cornell Celebration, recognizing CTL-connected inventors from the past two fiscal years.
An NSAID-related compound called ampyrone appears to safely boost production of the pigment melanin in human skin, according to a preclinical study led by Weill Cornell Medicine and National Eye Institute investigators.
The protein makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
At Cornell's first All-IT Town Hall, university leaders shared their vision for the next chapter of Evolve IT, emphasizing stronger connections, shared opportunities, and a future built on collaboration without losing the local relationships and expertise that make Cornell's Information Technology community successful.
Weill Cornell Medicine anesthesiologist Dr. Gunisha Kaur has been appointed to the U.S. Commission on International Religious Freedom, an agency that monitors the universal right to freedom of religion or belief.
Researchers have identified a site where a commonly used anesthetic binds to sodium ion channels, revealing a molecular mechanism that may explain how these drugs dampen communication between neurons.
At the heart of Cornell Tech’s hands-on, interdisciplinary approach is Studio, a program that brings students together across disciplines to build, test, and launch real-world solutions.
Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute to develop innovative support strategies for an understudied group of cancer patients: adolescents and young adults.